Oscar Health (OSCR) Set to Post Earnings on Thursday

Oscar Health (NYSE:OSCR) is expected to be announcing its Q3 2026 results before the market opens on Thursday, November 5th. Analysts expect Oscar Health to post earnings of ($0.1438) per share and revenue of $4.69 billion for the quarter. Individuals can check the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:00 AM ET.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Thursday, August 6th. The company reported $1.10 EPS for the quarter, topping the consensus estimate of $0.40 by $0.70. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%. The business had revenue of $4.88 billion for the quarter, compared to analysts’ expectations of $4.73 billion. During the same quarter in the previous year, the firm posted ($0.89) earnings per share. The company’s revenue was up 70.4% compared to the same quarter last year. On average, analysts expect Oscar Health to post $1.83 EPS for the current fiscal year and $2.22 EPS for the next fiscal year.

Oscar Health Stock Up 2.7%

NYSE OSCR traded up $0.83 during mid-day trading on Tuesday, reaching $31.83. 832,542 shares of the company’s stock traded hands, compared to its average volume of 6,668,362. Oscar Health has a 1-year low of $10.69 and a 1-year high of $35.01. The company has a fifty day simple moving average of $31.67 and a 200-day simple moving average of $23.64. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.21. The company has a market cap of $9.82 billion, a price-to-earnings ratio of 22.73, a P/E/G ratio of 0.33 and a beta of 2.47.

Insider Transactions at Oscar Health

In related news, Director Mario Schlosser sold 31,422 shares of the business’s stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total value of $988,221.90. Following the completion of the sale, the director directly owned 449,444 shares of the company’s stock, valued at $14,135,013.80. The trade was a 6.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Victoria Baltrus sold 958 shares of the company’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total value of $30,129.10. Following the sale, the chief accounting officer owned 213,631 shares in the company, valued at $6,718,694.95. The trade was a 0.45% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 874,451 shares of company stock valued at $26,761,671 over the last 90 days. Corporate insiders own 22.64% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on OSCR shares. Zacks Research raised Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 6th. Stephens reissued an “equal weight” rating and set a $34.00 price target on shares of Oscar Health in a research report on Thursday, September 17th. Wells Fargo & Company lifted their price target on shares of Oscar Health from $20.00 to $27.00 and gave the stock an “equal weight” rating in a research note on Thursday, August 13th. Robert W. Baird upped their price target on shares of Oscar Health from $27.00 to $33.00 and gave the company a “neutral” rating in a report on Thursday, September 17th. Finally, Weiss Ratings raised shares of Oscar Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Oscar Health currently has an average rating of “Hold” and an average target price of $34.90.

Oscar Health Company Profile

Oscar Health, Inc is a technology-focused health insurance company that provides health plans and related services in the United States. The company primarily serves individuals and families purchasing coverage through the Affordable Care Act’s health insurance marketplace, as well as small businesses and their employees.

Oscar combines health insurance products with digital tools designed to help members manage their care. Its services include online enrollment, virtual care, provider search and appointment support, care navigation, claims and benefits information, and member engagement through web and mobile applications.